What's in Azidus Brasil's pipeline?

Azidus Brasil has 11 drugs in our index: 3 marketed, 0 filed, 4 in Phase 3, 1 in Phase 2, 2 in Phase 1.

Which companies overlap with Azidus Brasil's portfolio?

No competitive overlap detected.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/azidus-brasil.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-09 · How we verify

Azidus Brasil — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Azidus Brasil pipeline: 3 marketed, 0 filed, 4 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

3 marketed 0 filed 4 Phase 3 1 Phase 2 2 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Area
halobetasol	halobetasol	marketed	Other
Sominex	Sominex	marketed	Other
Tobradex	Tobradex	marketed	Other
Nordette	Nordette	phase 3	Other
Flavonid	Flavonid	phase 3	Other
Tobracort	Tobracort	phase 3	Other
Botulift	Botulift	phase 3	Other

Therapeutic area mix

Other · 10

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

No competitive overlap data.

Subscribe to ongoing alerts

Every new pipeline event for Azidus Brasil:

Cite this brief

Drug Landscape (2026). Azidus Brasil — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/azidus-brasil. Accessed 2026-06-09.